Verition Fund Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-46,599
| Closed | -$2.74M | – | 2401 |
|
|
2023
Q4 | $2.74M | Sell |
46,599
-159,880
| -77% | -$9.39M | 0.02% | 590 |
|
|
2023
Q3 | $8.99M | Buy |
206,479
+198,801
| +2,589% | +$8.66M | 0.1% | 226 |
|
|
2023
Q2 | $277K | Sell |
7,678
-3,978
| -34% | -$144K | ﹤0.01% | 1389 |
|
|
2023
Q1 | $433K | Buy |
11,656
+6,145
| +112% | +$228K | 0.01% | 1214 |
|
|
2022
Q4 | $250K | Sell |
5,511
-162
| -3% | -$7.34K | ﹤0.01% | 1267 |
|
|
2022
Q3 | $396K | Hold |
5,673
| – | – | ﹤0.01% | 1600 |
|
|
2022
Q2 | $381K | Buy |
+5,673
| New | +$381K | 0.01% | 1538 |
|
|
2022
Q1 | – | Sell |
-32,027
| Closed | -$4.7M | – | 2338 |
|
|
2021
Q4 | $4.7M | Buy |
32,027
+9,231
| +40% | +$1.35M | 0.03% | 281 |
|
|
2021
Q3 | $4.03M | Buy |
22,796
+19,631
| +620% | +$3.47M | 0.03% | 238 |
|
|
2021
Q2 | $511K | Buy |
+3,165
| New | +$511K | ﹤0.01% | 960 |
|
|
2018
Q2 | – | Sell |
-9,141
| Closed | -$281K | – | 1313 |
|
|
2018
Q1 | $281K | Buy |
+9,141
| New | +$281K | 0.02% | 811 |
|